secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001651308-25-000078
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene issues 133M shares internally for re-domiciliation from Cayman to Switzerland
--------------------------------------------------------------------------------

- Issued 133,000,000 ordinary shares to subsidiary BGNC2 in exchange for 13.7% of BeiGene UK Ltd.
- Shares will be deemed treasury shares under Swiss law upon completion of planned re-domiciliation.
- Issuance relies on Section 4(a)(2) exemption; shares will be cancelled if re-domiciliation abandoned.
- Shares held for benefit of equity award holders under the 2016 Share Option and Incentive Plan.
- Swiss issuance stamp tax and withholding tax exemptions apply as shares are created before re-domiciliation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000078/0001651308-25-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000078/bgne-20250513.htm
  HTML page:      https://secwatch.observer/filing/0001651308-25-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer